{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:02:35Z","timestamp":1791417755559,"version":"4.3.3"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2006,9,21]],"date-time":"2006-09-21T00:00:00Z","timestamp":1158796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This study was aimed at the characterization of a gene expression signature of the pluripotent hematopoietic CD34+ stem cell in idiopathic myelofibrosis (IM), which would eventually provide novel pathogenetic insights and\/or diagnostic\/prognostic information. Aberrantly regulated genes were revealed by transcriptome comparative microarray analysis of normal and IM CD34+ cells; selected genes were also assayed in granulocytes. One-hundred seventy four differentially expressed genes were identified and in part validated by quantitative polymerase chain reaction. Altered gene expression was corroborated by the detection of abnormally high CD9 or CD164, and low CXCR4, membrane protein expression in IM CD34+ cells. According to class prediction analysis, a set of eight genes (CD9, GAS2, DLK1, CDH1, WT1, NFE2, HMGA2, and CXCR4) properly recognized IM from normal CD34+ cells. These genes were aberrantly regulated also in IM granulocytes that could be reliably differentiated from control polycythemia vera and essential thrombocythemia granulocytes in 100% and 81% of cases, respectively. Abnormal expression of HMGA2 and CXCR4 in IM granulocytes was dependent on the presence and the mutational status of JAK2V617F mutation. The expression levels of both CD9 and DLK1 were associated with the platelet count, whereas higher WT1 expression levels identified IM patients with more active disease, as revealed by elevated CD34+ cell count and higher severity score. In conclusion, molecular profiling of IM CD34+ cells uncovered a limited number of genes with altered expression that, beyond their putative role in disease pathogenesis, are associated with patients' clinical characteristics and may have potential prognostic application.<\/jats:p>","DOI":"10.1634\/stemcells.2006-0351","type":"journal-article","created":{"date-parts":[[2006,9,22]],"date-time":"2006-09-22T01:12:32Z","timestamp":1158887552000},"page":"165-173","source":"Crossref","is-referenced-by-count":116,"title":["Molecular Profiling of CD34+ Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (<i>WT1<\/i>)"],"prefix":"10.1093","volume":"25","author":[{"given":"Paola","family":"Guglielmelli","sequence":"first","affiliation":[{"name":"Department of Hematology, Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Zini","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Biological Chemistry Section, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Bogani","sequence":"additional","affiliation":[{"name":"Department of Hematology, Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Salati","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Biological Chemistry Section, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pancrazzi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Biological Chemistry Section, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mannelli","sequence":"additional","affiliation":[{"name":"Department of Hematology, Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Biological Chemistry Section, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Caroline","family":"Le Bousse-Kerdil\u00e8s","sequence":"additional","affiliation":[{"name":"INSERM U602, University Paris 11, Institut Andr\u00e9 Lwoff, Villejuif Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bosi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Barosi","sequence":"additional","affiliation":[{"name":"Unit of Clinical Epidemiology, IRCCS Policlinico S. Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Migliaccio","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore Sanit\u00e0, Rome, Italy"},{"name":"Department of Pathology, University of Illinois at Chicago, Illinois, USA, on behalf of the MPD Research Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Manfredini","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Biological Chemistry Section, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro M.","family":"Vannucchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,9,21]]},"reference":[{"key":"2022011304423435300_bib1","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"2022011304423435300_bib2","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.1999.17.9.2954","article-title":"Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines","volume":"17","author":"Barosi","year":"1999","journal-title":"J Clin Oncol"},{"key":"2022011304423435300_bib3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","article-title":"Myelofibrosis with myeloid metaplasia","volume":"342","author":"Tefferi","year":"2000","journal-title":"N Engl J Med"},{"key":"2022011304423435300_bib4","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2004-06-2485","article-title":"The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis","volume":"105","author":"Xu","year":"2005","journal-title":"Blood"},{"key":"2022011304423435300_bib5","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1182\/blood-2004-08-3238","article-title":"The constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases","volume":"105","author":"Xu","year":"2005","journal-title":"Blood"},{"key":"2022011304423435300_bib6","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood.V98.12.3249","article-title":"Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia","volume":"98","author":"Barosi","year":"2001","journal-title":"Blood"},{"key":"2022011304423435300_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2141.2004.05280.x","article-title":"Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: A prospective evaluation of prognostic value in 94 patients","volume":"128","author":"Arora","year":"2005","journal-title":"Br J Haematol"},{"key":"2022011304423435300_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1182\/blood-2004-07-2864","article-title":"Leukemic transformation in myelofibrosis with myeloid metaplasia: A single-institution experience with 91 cases","volume":"105","author":"Mesa","year":"2005","journal-title":"Blood"},{"key":"2022011304423435300_bib9","first-page":"307","article-title":"Properties of myelofibrosis-derived fibroblasts","volume":"154","author":"Castro-Malaspina","year":"1984","journal-title":"Prog Clin Biol Res"},{"key":"2022011304423435300_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0369-8114(00)00021-3","article-title":"Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis","volume":"49","author":"Le Bousse-Kerdiles","year":"2001","journal-title":"Pathol Biol (Paris)"},{"key":"2022011304423435300_bib11","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1182\/blood.V90.11.4369","article-title":"High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice","volume":"90","author":"Villeval","year":"1997","journal-title":"Blood"},{"key":"2022011304423435300_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1182\/blood.V88.2.402.bloodjournal882402","article-title":"A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): Reversal of disease by bone marrow transplantation","volume":"88","author":"Yan","year":"1996","journal-title":"Blood"},{"key":"2022011304423435300_bib13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2002-06-1913","article-title":"Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice)","volume":"100","author":"Vannucchi","year":"2002","journal-title":"Blood"},{"key":"2022011304423435300_bib14","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L Is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med"},{"key":"2022011304423435300_bib15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0002-9440(10)62056-1","article-title":"Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis","volume":"167","author":"Vannucchi","year":"2005","journal-title":"Am J Pathol"},{"key":"2022011304423435300_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"2022011304423435300_bib17","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"2022011304423435300_bib18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"2022011304423435300_bib19","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"2022011304423435300_bib20","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2006-01-013540","article-title":"The JAK2\u2013V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera","volume":"108","author":"Lippert","year":"2006","journal-title":"Blood"},{"key":"2022011304423435300_bib21","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/sj.leu.2403902","article-title":"Clinical implications of the JAK2 V617F mutation in essential thrombocythemia","volume":"19","author":"Antonioli","year":"2005","journal-title":"Leukemia"},{"key":"2022011304423435300_bib22","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"key":"2022011304423435300_bib23","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","article-title":"Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model","volume":"107","author":"Wernig","year":"2006","journal-title":"Blood"},{"key":"2022011304423435300_bib24","first-page":"871","article-title":"Gain of function, loss of control - a molecular basis for chronic myeloproliferative disorders","volume":"90","author":"Cazzola","year":"2005","journal-title":"Haematologica"},{"key":"2022011304423435300_bib25","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/blood-2005-03-1287","article-title":"On the molecular origins of the chronic myeloproliferative disorders: It all makes sense","volume":"105","author":"Kaushansky","year":"2005","journal-title":"Blood"},{"key":"2022011304423435300_bib26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood-2004-01-0274","article-title":"Genomic approaches to hematologic malignancies","volume":"104","author":"Ebert","year":"2004","journal-title":"Blood"},{"key":"2022011304423435300_bib27","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood-2003-03-0691","article-title":"Does cytogenetic mosaicism in CD34+CD38low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis?","volume":"102","author":"Bilhou-Nabera","year":"2003","journal-title":"Blood"},{"key":"2022011304423435300_bib28","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2141.1999.01262.x","article-title":"The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia","volume":"104","author":"Barosi","year":"1999","journal-title":"Br J Haematol"},{"key":"2022011304423435300_bib29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V88.3.1013.1013","article-title":"Prognostic factors in agnogenic myeloid metaplasia: A report on 195 cases with a new scoring system","volume":"88","author":"Dupriez","year":"1996","journal-title":"Blood"},{"key":"2022011304423435300_bib30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1200\/JCO.2004.08.160","article-title":"Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: A phase II trial","volume":"22","author":"Marchetti","year":"2004","journal-title":"J Clin Oncol"},{"key":"2022011304423435300_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1097-0320(19980415)34:2<61::AID-CYTO1>3.0.CO;2-F","article-title":"Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering","volume":"34","author":"Keeney","year":"1998","journal-title":"Cytometry"},{"key":"2022011304423435300_bib32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1634\/stemcells.2004-0265","article-title":"The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment","volume":"23","author":"Manfredini","year":"2005","journal-title":"Stem Cells"},{"key":"2022011304423435300_bib33","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/PL00000933","article-title":"Tetraspanins","volume":"58","author":"Boucheix","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"2022011304423435300_bib34","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1182\/blood.V92.8.2613","article-title":"The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis","volume":"92","author":"Zannettino","year":"1998","journal-title":"Blood"},{"key":"2022011304423435300_bib35","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","article-title":"CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment","volume":"107","author":"Burger","year":"2006","journal-title":"Blood"},{"key":"2022011304423435300_bib36","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood.V99.6.2037","article-title":"Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells","volume":"99","author":"Steidl","year":"2002","journal-title":"Blood"},{"key":"2022011304423435300_bib37","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1182\/blood.V97.7.1982","article-title":"CD9 and megakaryocyte differentiation","volume":"97","author":"Clay","year":"2001","journal-title":"Blood"},{"key":"2022011304423435300_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1634\/stemcells.2004-0131","article-title":"Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays","volume":"23","author":"Jones","year":"2005","journal-title":"Stem Cells"},{"key":"2022011304423435300_bib39","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1126\/science.1094291","article-title":"Convergence of Wnt, beta-catenin, and cadherin pathways","volume":"303","author":"Nelson","year":"2004","journal-title":"Science"},{"key":"2022011304423435300_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.seminhematol.2005.05.023","article-title":"Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: The role of neutrophils","volume":"42","author":"Falanga","year":"2005","journal-title":"Semin Hematol"},{"key":"2022011304423435300_bib41","volume-title":"Gene Expression Omnibus profiles"},{"key":"2022011304423435300_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2141.2005.05743.x","article-title":"Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia","volume":"131","author":"Tefferi","year":"2005","journal-title":"Br J Haematol"},{"key":"2022011304423435300_bib43","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood-2005-04-1515","article-title":"The Jak2V617F mutation, PRV-1 overexpression and EEC formation define a similar cohort of MPD patients","volume":"106","author":"Goerttler","year":"2005","journal-title":"Blood"},{"key":"2022011304423435300_bib44","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1182\/blood-2005-05-1889","article-title":"Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2","volume":"106","author":"Kralovics","year":"2005","journal-title":"Blood"},{"key":"2022011304423435300_bib45","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.leu.2403817","article-title":"Wilms' tumour gene 1 (WT1) in human neoplasia","volume":"19","author":"Keilholz","year":"2005","journal-title":"Leukemia"},{"key":"2022011304423435300_bib46","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1200\/JCO.2003.10.503","article-title":"Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes","volume":"21","author":"Cilloni","year":"2003","journal-title":"J Clin Oncol"},{"key":"2022011304423435300_bib47","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","article-title":"WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia","volume":"84","author":"Inoue","year":"1994","journal-title":"Blood"},{"key":"2022011304423435300_bib48","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1182\/blood.V91.8.2969.2969_2969_2976","article-title":"Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells","volume":"91","author":"Inoue","year":"1998","journal-title":"Blood"},{"key":"2022011304423435300_bib49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0145-2126(99)00037-5","article-title":"Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)","volume":"23","author":"Tsuboi","year":"1999","journal-title":"Leuk Res"},{"key":"2022011304423435300_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1349-7006.2006.00169.x","article-title":"Wilms' tumor gene WT1 17AA(-)\/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro","volume":"97","author":"Jomgeow","year":"2006","journal-title":"Cancer Sci"},{"key":"2022011304423435300_bib51","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/sj.leu.2403832","article-title":"Dlk1 in normal and abnormal hematopoiesis","volume":"19","author":"Sakajiri","year":"2005","journal-title":"Leukemia"},{"key":"2022011304423435300_bib52","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/blood.V98.2.422","article-title":"Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction","volume":"98","author":"Miyazato","year":"2001","journal-title":"Blood"},{"key":"2022011304423435300_bib53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/path.1505","article-title":"The human Delta-like 1 homologue is implicated in the progression of liver fibrosis in biliary atresia","volume":"202","author":"Huang","year":"2004","journal-title":"J Pathol"},{"key":"2022011304423435300_bib54","doi-asserted-by":"crossref","first-page":"13885","DOI":"10.1073\/pnas.0405884101","article-title":"Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression","volume":"101","author":"Oka","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022011304423435300_bib55","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1182\/blood-2005-04-1520","article-title":"Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)","volume":"106","author":"Barosi","year":"2005","journal-title":"Blood"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1634%2Fstemcells.2006-0351","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/stemcells.2006-0351","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/stemcells.2006-0351","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/25\/1\/165\/41960293\/stmcls_25_1_165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/25\/1\/165\/41960293\/stmcls_25_1_165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:52:23Z","timestamp":1642560743000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/25\/1\/165-173\/6401684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2006,9,21]]},"published-print":{"date-parts":[[2007,1,1]]}},"URL":"https:\/\/doi.org\/10.1634\/stemcells.2006-0351","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,1,1]]},"published":{"date-parts":[[2006,9,21]]}}}